Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Cash & Current Investments: 2020-2024

Historic Cash & Current Investments for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $49.7 million.

  • Oncology Institute's Cash & Current Investments fell 4165.23% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year decrease of 4165.23%. This contributed to the annual value of $49.7 million for FY2024, which is 4005.31% down from last year.
  • Oncology Institute's Cash & Current Investments amounted to $49.7 million in FY2024, which was down 4005.31% from $82.9 million recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Cash & Current Investments peaked at $115.2 million during FY2021, and registered a low of $6.0 million during FY2020.
  • In the last 5 years, Oncology Institute's Cash & Current Investments had a median value of $73.8 million in 2022 and averaged $65.5 million.
  • Per our database at Business Quant, Oncology Institute's Cash & Current Investments surged by 182020.67% in 2021 and then tumbled by 4005.31% in 2024.
  • Oncology Institute's Cash & Current Investments (Annual) stood at $6.0 million in 2020, then skyrocketed by 1820.21% to $115.2 million in 2021, then tumbled by 35.92% to $73.8 million in 2022, then increased by 12.26% to $82.9 million in 2023, then tumbled by 40.05% to $49.7 million in 2024.
  • Its last three reported values are $49.7 million in FY2024, $82.9 million for FY2023, and $73.8 million during FY2022.